Search Results

Seoul National University Bundang Hospital Biomedical Research Institute announced that it concluded the MOU on November 15, 2022, to standardize clinico genomic research using Cipherome, Inc.’s precision medicine research platform at Precision Medicine Center.

Cipherome, Inc. (“Cipherome”), a Silicon Valley-based, genomic bioinformatics start-up, has joined the American Heart Association Center for Health Technology & Innovation’s (the Center) Innovators’ Network.

Can a medical tool predict the risk of certain medications based on a patient’s genetics, and, if so, could this information lead to doctors customizing a patient’s drug therapy? The tool being studied at DHR Health Institute for Research & Development to answer these questions is Cipherome’s Xentinel® Lighthouse, and this pilot study will also evaluate the resulting savings in health-care costs.